Chlamydia trachomatis GlgA Is Secreted into Host Cell Cytoplasm

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Lu, Chunxue ^a,b   Lei, Lei ^b   Peng, Bo ^a,b   Tang, Lingli ^b   Ding, Honglei ^b   Gong, Siqi ^b   Li, Zhongyu ^a   Wu, Yimou ^a   Zhong, Guangming ^b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE; PROTEINASE;

ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; CELL INCLUSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME LOCALIZATION; ENZYME RELEASE; FEMALE; GENE EXPRESSION; GLGA GENE; GLYCOGEN SYNTHESIS; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; NONHUMAN; PROTEIN EXPRESSION; SEROTYPE; SIGNAL TRANSDUCTION;

EID: 84880848934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068764     Document Type: Article

References (37)

1. Sherman KJ, Daling JR, Stergachis A, Weiss NS, Foy HM, et al. (1990) Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis 17: 115-121. doi:10.1097/00007435-199007000-00001. PubMed: 2247800.
2. Peterman TA, Tian LH, Metcalf CA, Satterwhite CL, Malotte CK, et al. (2006) High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 145: 564-572. doi:10.7326/0003-4819-145-8-200610170-00005. PubMed: 17043338.
3. Centers for Disease Control and Prevention C (November 2009) Sexually Transmitted Disease Surveillance (2008). In: Services USDoHaH, editor. Atlanta, GA: http://www.cdc.gov/std/stats08/toc.htm.
4. Stephens RS, (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11: 44-51. doi:10.1016/S0966-842X(02)00011-2. PubMed: 12526854.
5. Zhong G, (2009) Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol 17: 467-474. doi:10.1016/j.tim.2009.07.007. PubMed: 19765998.
6. Cheng W, Shivshankar P, Li Z, Chen L, Yeh IT, et al. (2008) Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 76: 515-522. doi:10.1128/IAI.01064-07. PubMed: 18025098.
7. Chen L, Lei L, Chang X, Li Z, Lu C, et al. (2010) Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J Immunol 184: 2602-2610. doi:10.4049/jimmunol.0901593. PubMed: 20124098.
8. Hackstadt T, Fischer ER, Scidmore MA, Rockey DD, Heinzen RA, (1997) Origins and functions of the chlamydial inclusion. Trends Microbiol 5: 288-293. doi:10.1016/S0966-842X(97)01061-5. PubMed: 9234512.
9. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, et al. (2004) A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 101: 10166-10171. doi:10.1073/pnas.0402829101. PubMed: 15199184.
10. Engel J, (2004) Tarp and Arp: How Chlamydia induces its own entry. Proc Natl Acad Sci U S A 101: 9947-9948. doi:10.1073/pnas.0403633101. PubMed: 15226494.
11. Hower S, Wolf K, Fields KA, (2009) Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 72: 1423-1437. doi:10.1111/j.1365-2958.2009.06732.x. PubMed: 19460098.
12. Scidmore MA, Fischer ER, Hackstadt T, (2003) Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect Immun 71: 973-984. doi:10.1128/IAI.71.2.973-984.2003. PubMed: 12540580.
13. Rockey DD, Scidmore MA, Bannantine JP, Brown WJ, (2002) Proteins in the chlamydial inclusion membrane. Microbes Infect 4: 333-340. doi:10.1016/S1286-4579(02)01546-0. PubMed: 11909744.
14. Li Z, Chen C, Chen D, Wu Y, Zhong Y, et al. (2008) Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun 76: 2746-2757. doi:10.1128/IAI.00010-08. PubMed: 18391011.
15. Valdivia RH, (2008) Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr Opin Microbiol 11: 53-59. doi:10.1016/j.mib.2008.01.003. PubMed: 18299248.
16. Fields KA, Mead DJ, Dooley CA, Hackstadt T, (2003) Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol Microbiol 48: 671-683. doi:10.1046/j.1365-2958.2003.03462.x. PubMed: 12694613.
17. Wu X, Lei L, Gong S, Chen D, Flores R, et al. (2011) The chlamydial periplasmic stress response serine protease cHtrA is secreted into host cell cytosol. BMC Microbiol 11: 87. doi:10.1186/1471-2180-11-87. PubMed: 21527029.
18. Li Z, Chen D, Zhong Y, Wang S, Zhong G, (2008) The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun 76: 3415-3428. doi:10.1128/IAI.01377-07. PubMed: 18474640.
19. Gong S, (2011) Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by a C1 compound. Microbiology.
20. Qi M, Lei L, Gong S, Liu Q, Delisa MP, et al. (2011) Chlamydia trachomatis Secretion of an Immunodominant Hypothetical Protein (CT795) into Host Cell Cytoplasm. J Bacteriol 193: 2498-2509. doi:10.1128/JB.01301-10. PubMed: 21441519.
21. Lei L, Qi M, Budrys N, Schenken R, Zhong G, (2011) Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm. Microb Pathog 51: 101-109. doi:10.1016/j.micpath.2011.05.002. PubMed: 21605656.
22. Zhong G, Fan P, Ji H, Dong F, Huang Y, (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942. doi:10.1084/jem.193.8.935. PubMed: 11304554.
23. Gilkes MJ, Smith CH, Sowa J, (1958) Staining of the inclusion bodies of trachoma and inclusion conjunctivitis. Br J Ophthalmol 42: 473-477. doi:10.1136/bjo.42.8.473. PubMed: 13572759.
24. Chun Y, Yin ZD, (1998) Glycogen assay for diagnosis of female genital Chlamydia trachomatis infection. J Clin Microbiol 36: 1081-1082. PubMed: 9542941.
25. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, et al. (1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754-759. doi:10.1126/science.282.5389.754. PubMed: 9784136.
26. O'Connell CM, Ingalls RR, Andrews CW Jr., Scurlock AM, Darville T, (2007) Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 179: 4027-4034. PubMed: 17785841.
27. Chiappino ML, Dawson C, Schachter J, Nichols BA, (1995) Cytochemical localization of glycogen in Chlamydia trachomatis inclusions. J Bacteriol 177: 5358-5363. PubMed: 7545158.
28. Carlson JH, Whitmire WM, Crane DD, Wicke L, Virtaneva K, et al. (2008) The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect Immun 76: 2273-2283. doi:10.1128/IAI.00102-08. PubMed: 18347045.
29. Chen C, Chen D, Sharma J, Cheng W, Zhong Y, et al. (2006) The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect Immun 74: 4826-4840. doi:10.1128/IAI.00081-06. PubMed: 16861671.
30. Wang J, Zhang Y, Lu C, Lei L, Yu P, et al. (2010) A Genome-Wide Profiling of the Humoral Immune Response to Chlamydia trachomatis Infection Reveals Vaccine Candidate Antigens Expressed in Humans. J Immunol 185: 1670-1680. doi:10.4049/jimmunol.1001240. PubMed: 20581152.
31. Sharma J, Zhong Y, Dong F, Piper JM, Wang G, et al. (2006) Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 74: 1490-1499. doi:10.1128/IAI.74.3.1490-1499.2006. PubMed: 16495519.
32. Budrys NM, Gong S, Rodgers AK, Wang J, Louden C, et al. (2012) Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection. Obstet Gynecol 119: 1009-1016. doi:10.1097/AOG.0b013e3182519326. PubMed: 22525912.
33. Zhong Y, Weininger M, Pirbhai M, Dong F, Zhong G, (2006) Inhibition of staurosporine-induced activation of the proapoptotic multidomain Bcl-2 proteins Bax and Bak by three invasive chlamydial species. J Infect 53: 408-414. doi:10.1016/j.jinf.2005.12.028. PubMed: 16490255.
34. Fan T, Lu H, Hu H, Shi L, McClarty GA, et al. (1998) Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 187: 487-496. doi:10.1084/jem.187.4.487. PubMed: 9463399.
35. Sharma J, Bosnic AM, Piper JM, Zhong G, (2004) Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun 72: 7164-7171. doi:10.1128/IAI.72.12.7164-7171.2004. PubMed: 15557641.
36. Qi M, Gong S, Lei L, Liu Q, Zhong G, (2011) A Chlamydia trachomatis OmcB C-terminal fragment is released into host cell cytoplasm and is immunogenic in humans. Infect Immun.
37. Li Z, Lu C, Peng B, Zeng H, Zhou Z, et al. (2012) Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase. PLOS ONE 7: e32997. doi:10.1371/journal.pone.0032997. PubMed: 22427926.